Generalized Anxiety Disorder Market - Forecast(2019 - 2024)

Report Code: HCR 0216 Report Format: PDF + Excel (Delivery in 48 Hrs)
According to the World Health Organization (WHO) in 2017 approximately 300 million people were suffering from depression across the globe. Anxiety disorders are characterized by uncontrollable worry about daily events in a person’s life. Significant rise in the number of people suffering from generalized anxiety disorder has led to the growth of therapeutics market. The market would generate over $7.4 billion in revenues by 2023 at a CAGR of over 2.5% over the forecast period 2018-2023. The increase in the development and production of various drugs in this area is considered as one of the reasons for the market growth. On other hand, anxiety therapies and devices segment is growing with a remarkable Cumulative Annual Growth Rate owing to its high efficiency in treating anxiety related disorders and increasing demand. 

What is Generalized Anxiety Disorder?
Anxiety disorders are characterized by uncontrollable worry about daily events in a person’s life. The different kinds of anxiety include generalized anxiety disorder, panic disorder, specific phobias, agoraphobia, social anxiety disorder and separation anxiety disorder.

Generalized anxiety disorder (GAD) includes certain symptoms such as headache, tension, profuse sweating and tiredness. It has been observed that GAD occurs along with other anxiety disorder and depression. A large number of factors are responsible for the occurrence of GAD such as genetics, brain chemistry, and exposure to stressful event, family background, or life experiences.

This report incorporates an in-depth assessment of generalized anxiety disorder market by therapeutics type, therapies, devices and geography.

generalized-anxiety-disorder-market-image-industryarc

Market Research and Market Trends of Generalized Anxiety Disorder:
  • Fisher Wallace Simulator, an FDA-approved neurostimulation device to help treat depression, anxiety and insomnia. It is headband like device which stimulates the brain to release certain hormones such as dopamine which is known to reduce stress. Fisher Wallace Stimulator makes it possible to sit at home and engage in neurostimulation therapy. This can help patients to be naturally treated with the same effect as that of an antidepressant.
  • Scientists are currently working on finding the biomarkers that will categorize anxiety disorders more accurately. This data would help to understand the response of each drug to a particular disorder and thus could help to push therapeutic research forward driving the market during the forecast period.
  • Aloradine, a nasal spray-delivered agent, has a novel mechanism of action that stimulates nasal chemoreceptors. This transmits messages rapidly to the brain’s limbic system, amygdala and hypothalamus directly modulating brain autonomic, psychophysiological, and neuroendocrine responses and reducing stress and anxiety. This drug can be self-administered using a simple, low-cost device.
  • Currently, there is a lot of research going on to qualify a probiotic as a psychobiotic which would specifically provide mental health benefits. The effect of psychobiotic in the intestine would be conveyed to the brain and the other organs by the vagus nerve which is known to have a link between the nervous system and the digestive system.

Who are the Major Players in Generalized Anxiety Disorder market?
The companies referred to in the market research report include GlaxoSmithKline Pharmaceuticals Limited, Bristol-Myers Squibb, Sumitomo Dainippon Pharma, Noven Pharmaceuticals, Inc., Actavis Pharmaceutical Company, F. Hoffmann-La Roche, Abbott Laboratories, Eli Lilly and Company, Pfizer Inc., Shionogi and Company

What is our report scope?
The report incorporates in-depth assessment  the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis  so on to gauge the impact forces  potential opportunities  the market. Apart from this the report also includes a study  major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers  so on to comprehend the prevailing market dynamics at present  its impact during the forecast period 2018-2024.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase each report and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report
  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) Value ($M) data given at country level – for product types, end use applications by different industry verticals.
  • Underset the different dynamics influencing the market – key driving factors, challenges hidden opportunities.
  • Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT more.
  • Analyze the sales distribution channels across key geographies to improve top-line revenues.
  • Underset the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value bring efficiencies in your processes. 
  • Get a quick outlook on the market entropy – M&A’s, deals, partnerships, and product launches all key players for the past 4 years. 
  • Evaluate the supply-dem gaps, import-export statistics regulatory lscape for more than top 20 countries globally for the market. 
1. Generalized Anxiety Disorder Market - Overview
1.1. Definitions and Scope
2. Generalized Anxiety Disorder Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Generalized Anxiety Disorder Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Generalized Anxiety Disorder Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Generalized Anxiety Disorder Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Generalized Anxiety Disorder Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Generalized Anxiety Disorder Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Generalized Anxiety Disorder Market – By Therapeutics Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Antidepressant
8.3.1.1. Selective serotonin reuptake inhibitor (SSRI)
8.3.1.2. Serotonin norepinephrine reuptake inhibitor (SNRI)
8.3.1.3. Tricyclic antidepressant (TCA)
8.3.1.4. Monoamine Oxidase Inhibitors (MAOIs)
8.3.1.4.1. Benzodiazepines
8.3.1.4.2. Alprazolam
8.3.1.4.3. Chlordiazepoxide
8.3.1.4.4. Diazepam
8.3.1.4.5. Lorazepam
8.3.1.4.6. Others (Buspirone)
9. Generalized Anxiety Disorder Market – by Therapies type (Market Size -$Million / $Billion)
9.1. Interpersonal Therapy (IPT)
9.2. Behaviour Therapy
9.3. Cognitive Behavioral Therapy (CBT)
9.4. Mindfulness-based Cognitive Therapy (MBCT)
10. Generalized Anxiety Disorder Market – by Medical devices type (Market Size -$Million / $Billion)
10.1. Deep Brain Stimulation (DBS)
10.2. Electroconvulsive Therapy (ECT)
10.3. Trans cranial Magnetic Stimulation (TMS)
10.4. Vagus Nerve Stimulation (VNS)
11. Generalized Anxiety Disorder - By Geography (Market Size -$Million / $Billion)
11.1. Generalized Anxiety Disorder Market - North America Segment Research
11.2. North America Market Research (Million / $Billion)
11.2.1. Segment type Size and Market Size Analysis 
11.2.2. Revenue and Trends
11.2.3. Application Revenue and Trends by type of Application
11.2.4. Company Revenue and Product Analysis
11.2.5. North America Product type and Application Market Size
11.2.5.1. U.S.
11.2.5.2. Canada 
11.2.5.3. Mexico 
11.2.5.4. Rest of North America
11.3. Generalized Anxiety Disorder - South America Segment Research
11.4. South America Market Research (Market Size -$Million / $Billion)
11.4.1. Segment type Size and Market Size Analysis 
11.4.2. Revenue and Trends
11.4.3. Application Revenue and Trends by type of Application
11.4.4. Company Revenue and Product Analysis
11.4.5. South America Product type and Application Market Size
11.4.5.1. Brazil  
11.4.5.2. Venezuela
11.4.5.3. Argentina
11.4.5.4. Ecuador
11.4.5.5. Peru
11.4.5.6. Colombia 
11.4.5.7. Costa Rica
11.4.5.8. Rest of South America
11.5. Generalized Anxiety Disorder - Europe Segment Research
11.6. Europe Market Research (Market Size -$Million / $Billion)
11.6.1. Segment type Size and Market Size Analysis 
11.6.2. Revenue and Trends
11.6.3. Application Revenue and Trends by type of Application
11.6.4. Company Revenue and Product Analysis
11.6.5. Europe Segment Product type and Application Market Size
11.6.5.1. U.K  
11.6.5.2. Germany 
11.6.5.3. Italy 
11.6.5.4. France
11.6.5.5. Netherlands
11.6.5.6. Belgium
11.6.5.7. Spain
11.6.5.8. Denmark
11.6.5.9. Rest of Europe
11.7. Generalized Anxiety Disorder – APAC Segment Research
11.8. APAC Market Research (Market Size -$Million / $Billion)
11.8.1. Segment type Size and Market Size Analysis 
11.8.2. Revenue and Trends
11.8.3. Application Revenue and Trends by type of Application
11.8.4. Company Revenue and Product Analysis
11.8.5. APAC Segment – Product type and Application Market Size
11.8.5.1. China 
11.8.5.2. Australia
11.8.5.3. Japan 
11.8.5.4. South Korea
11.8.5.5. India
11.8.5.6. Taiwan
11.8.5.7. Malaysia
12. Generalized Anxiety Disorder Market - Entropy
12.1. New product launches
12.2. M&A's, collaborations, JVs and partnerships
13. Generalized Anxiety Disorder Market – Industry / Segment Competition landscape Premium
13.1. Market Share Analysis
13.1.1. Market Share by Country- Top companies
13.1.2. Market Share by Region- Top 10 companies
13.1.3. Market Share by type of Application – Top 10 companies
13.1.4. Market Share by type of Product / Product category- Top 10 companies
13.1.5. Market Share at global level- Top 10 companies
13.1.6. Best Practises for companies
14. Generalized Anxiety Disorder Market – Key Company List by Country Premium
15. Generalized Anxiety Disorder Market Company Analysis
15.1. Market Share, Company Revenue, Products, M&A, Developments
15.2. GlaxoSmithKline Pharmaceuticals Limited
15.3. Bristol-Myers Squibb
15.4. Sumitomo Dainippon Pharma
15.5. Noven Pharmaceuticals, Inc.
15.6. Actavis Pharmaceutical Company
15.7. F. Hoffmann-La Roche
15.8. Abbott Laboratories
15.9. Eli Lilly and Company
15.10. Pfizer Inc.
15.11. Shionogi and Company
15.12. Company 11
15.13. Company 12
15.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
16. Generalized Anxiety Disorder Market -Appendix
16.1. Abbreviations
16.2. Sources
17. Generalized Anxiety Disorder Market -Methodology Premium
17.1. Research Methodology
17.1.1. Company Expert Interviews
17.1.2. Industry Databases
17.1.3. Associations
17.1.4. Company News
17.1.5. Company Annual Reports
17.1.6. Application Trends
17.1.7. New Products and Product database
17.1.8. Company Transcripts
17.1.9. R&D Trends
17.1.10. Key Opinion Leaders Interviews
17.1.11. Supply and Demand Trends
List of Tables:
Table 1: Generalized Anxiety Disorder Market Overview 2019-2024
Table 2: Generalized Anxiety Disorder Market Leader Analysis 2018-2019 (US$)
Table 3: Generalized Anxiety Disorder Market Product Analysis 2018-2019 (US$)
Table 4: Generalized Anxiety Disorder Market End User Analysis 2018-2019 (US$)
Table 5: Generalized Anxiety Disorder Market Patent Analysis 2013-2018* (US$)
Table 6: Generalized Anxiety Disorder Market Financial Analysis 2018-2019 (US$)
Table 7: Generalized Anxiety Disorder Market Driver Analysis 2018-2019 (US$)
Table 8: Generalized Anxiety Disorder Market Challenges Analysis 2018-2019 (US$)
Table 9: Generalized Anxiety Disorder Market Constraint Analysis 2018-2019 (US$)
Table 10: Generalized Anxiety Disorder Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Generalized Anxiety Disorder Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Generalized Anxiety Disorder Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Generalized Anxiety Disorder Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Generalized Anxiety Disorder Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Generalized Anxiety Disorder Market Value Chain Analysis 2018-2019 (US$)
Table 16: Generalized Anxiety Disorder Market Pricing Analysis 2019-2024 (US$)
Table 17: Generalized Anxiety Disorder Market Opportunities Analysis 2019-2024 (US$)
Table 18: Generalized Anxiety Disorder Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Generalized Anxiety Disorder Market Supplier Analysis 2018-2019 (US$)
Table 20: Generalized Anxiety Disorder Market Distributor Analysis 2018-2019 (US$)
Table 21: Generalized Anxiety Disorder Market Trend Analysis 2018-2019 (US$)
Table 22: Generalized Anxiety Disorder Market Size 2018 (US$)
Table 23: Generalized Anxiety Disorder Market Forecast Analysis 2019-2024 (US$)
Table 24: Generalized Anxiety Disorder Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Generalized Anxiety Disorder Market, Revenue & Volume, By Therapeutics Type, 2019-2024 ($)
Table 26: Generalized Anxiety Disorder Market By Therapeutics Type, Revenue & Volume, By Antidepressant, 2019-2024 ($)
Table 27: Generalized Anxiety Disorder Market, Revenue & Volume, By Therapies type, 2019-2024 ($)
Table 28: Generalized Anxiety Disorder Market By Therapies type, Revenue & Volume, By Interpersonal Therapy (IPT), 2019-2024 ($)
Table 29: Generalized Anxiety Disorder Market By Therapies type, Revenue & Volume, By Behaviour Therapy, 2019-2024 ($)
Table 30: Generalized Anxiety Disorder Market By Therapies type, Revenue & Volume, By Cognitive Behavioral Therapy (CBT), 2019-2024 ($)
Table 31: Generalized Anxiety Disorder Market By Therapies type, Revenue & Volume, By Mindfulness-based Cognitive Therapy (MBCT), 2019-2024 ($)
Table 32: Generalized Anxiety Disorder Market, Revenue & Volume, By Medical devices type, 2019-2024 ($)
Table 33: Generalized Anxiety Disorder Market By Medical devices type, Revenue & Volume, By Deep Brain Stimulation (DBS), 2019-2024 ($)
Table 34: Generalized Anxiety Disorder Market By Medical devices type, Revenue & Volume, By Electroconvulsive Therapy (ECT), 2019-2024 ($)
Table 35: Generalized Anxiety Disorder Market By Medical devices type, Revenue & Volume, By Trans cranial Magnetic Stimulation (TMS), 2019-2024 ($)
Table 36: Generalized Anxiety Disorder Market By Medical devices type, Revenue & Volume, By Vagus Nerve Stimulation (VNS), 2019-2024 ($)
Table 37: North America Generalized Anxiety Disorder Market, Revenue & Volume, By Therapeutics Type, 2019-2024 ($)
Table 38: North America Generalized Anxiety Disorder Market, Revenue & Volume, By Therapies type, 2019-2024 ($)
Table 39: North America Generalized Anxiety Disorder Market, Revenue & Volume, By Medical devices type, 2019-2024 ($)
Table 40: South america Generalized Anxiety Disorder Market, Revenue & Volume, By Therapeutics Type, 2019-2024 ($)
Table 41: South america Generalized Anxiety Disorder Market, Revenue & Volume, By Therapies type, 2019-2024 ($)
Table 42: South america Generalized Anxiety Disorder Market, Revenue & Volume, By Medical devices type, 2019-2024 ($)
Table 43: Europe Generalized Anxiety Disorder Market, Revenue & Volume, By Therapeutics Type, 2019-2024 ($)
Table 44: Europe Generalized Anxiety Disorder Market, Revenue & Volume, By Therapies type, 2019-2024 ($)
Table 45: Europe Generalized Anxiety Disorder Market, Revenue & Volume, By Medical devices type, 2019-2024 ($)
Table 46: APAC Generalized Anxiety Disorder Market, Revenue & Volume, By Therapeutics Type, 2019-2024 ($)
Table 47: APAC Generalized Anxiety Disorder Market, Revenue & Volume, By Therapies type, 2019-2024 ($)
Table 48: APAC Generalized Anxiety Disorder Market, Revenue & Volume, By Medical devices type, 2019-2024 ($)
Table 49: Middle East & Africa Generalized Anxiety Disorder Market, Revenue & Volume, By Therapeutics Type, 2019-2024 ($)
Table 50: Middle East & Africa Generalized Anxiety Disorder Market, Revenue & Volume, By Therapies type, 2019-2024 ($)
Table 51: Middle East & Africa Generalized Anxiety Disorder Market, Revenue & Volume, By Medical devices type, 2019-2024 ($)
Table 52: Russia Generalized Anxiety Disorder Market, Revenue & Volume, By Therapeutics Type, 2019-2024 ($)
Table 53: Russia Generalized Anxiety Disorder Market, Revenue & Volume, By Therapies type, 2019-2024 ($)
Table 54: Russia Generalized Anxiety Disorder Market, Revenue & Volume, By Medical devices type, 2019-2024 ($)
Table 55: Israel Generalized Anxiety Disorder Market, Revenue & Volume, By Therapeutics Type, 2019-2024 ($)
Table 56: Israel Generalized Anxiety Disorder Market, Revenue & Volume, By Therapies type, 2019-2024 ($)
Table 57: Israel Generalized Anxiety Disorder Market, Revenue & Volume, By Medical devices type, 2019-2024 ($)
Table 58: Top Companies 2018 (US$) Generalized Anxiety Disorder Market, Revenue & Volume
Table 59: Product Launch 2018-2019 Generalized Anxiety Disorder Market, Revenue & Volume
Table 60: Mergers & Acquistions 2018-2019 Generalized Anxiety Disorder Market, Revenue & Volume

List of Figures:

Figure 1: Overview of Generalized Anxiety Disorder Market 2019-2024
Figure 2: Market Share Analysis for Generalized Anxiety Disorder Market 2018 (US$)
Figure 3: Product Comparison in Generalized Anxiety Disorder Market 2018-2019 (US$)
Figure 4: End User Profile for Generalized Anxiety Disorder Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Generalized Anxiety Disorder Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Generalized Anxiety Disorder Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Generalized Anxiety Disorder Market 2018-2019
Figure 8: Ecosystem Analysis in Generalized Anxiety Disorder Market 2018
Figure 9: Average Selling Price in Generalized Anxiety Disorder Market 2019-2024
Figure 10: Top Opportunites in Generalized Anxiety Disorder Market 2018-2019
Figure 11: Market Life Cycle Analysis in Generalized Anxiety Disorder Market
Figure 12: GlobalBy Therapeutics Type Generalized Anxiety Disorder Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Therapies type Generalized Anxiety Disorder Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy Medical devices type Generalized Anxiety Disorder Market Revenue, 2019-2024 ($)
Figure 15: Global Generalized Anxiety Disorder Market - By Geography
Figure 16: Global Generalized Anxiety Disorder Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 17: Global Generalized Anxiety Disorder Market CAGR, By Geography, 2019-2024 (%)
Figure 18: North America Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 19: US Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 20: US GDP and Population, 2018-2019 ($)
Figure 21: US GDP – Composition of 2018, By Sector of Origin
Figure 22: US Export and Import Value & Volume, 2018-2019 ($)
Figure 23: Canada Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 24: Canada GDP and Population, 2018-2019 ($)
Figure 25: Canada GDP – Composition of 2018, By Sector of Origin
Figure 26: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 27: Mexico Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 28: Mexico GDP and Population, 2018-2019 ($)
Figure 29: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 30: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 31: South America Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 33: Brazil GDP and Population, 2018-2019 ($)
Figure 34: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 35: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 36: Venezuela Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 37: Venezuela GDP and Population, 2018-2019 ($)
Figure 38: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 39: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 40: Argentina Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 41: Argentina GDP and Population, 2018-2019 ($)
Figure 42: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 43: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 44: Ecuador Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 45: Ecuador GDP and Population, 2018-2019 ($)
Figure 46: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 47: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 48: Peru Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 49: Peru GDP and Population, 2018-2019 ($)
Figure 50: Peru GDP – Composition of 2018, By Sector of Origin
Figure 51: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 52: Colombia Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 53: Colombia GDP and Population, 2018-2019 ($)
Figure 54: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 55: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 56: Costa Rica Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 57: Costa Rica GDP and Population, 2018-2019 ($)
Figure 58: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 59: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 60: Europe Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 61: U.K Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 62: U.K GDP and Population, 2018-2019 ($)
Figure 63: U.K GDP – Composition of 2018, By Sector of Origin
Figure 64: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 65: Germany Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 66: Germany GDP and Population, 2018-2019 ($)
Figure 67: Germany GDP – Composition of 2018, By Sector of Origin
Figure 68: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 69: Italy Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 70: Italy GDP and Population, 2018-2019 ($)
Figure 71: Italy GDP – Composition of 2018, By Sector of Origin
Figure 72: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 73: France Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 74: France GDP and Population, 2018-2019 ($)
Figure 75: France GDP – Composition of 2018, By Sector of Origin
Figure 76: France Export and Import Value & Volume, 2018-2019 ($)
Figure 77: Netherlands Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 78: Netherlands GDP and Population, 2018-2019 ($)
Figure 79: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 80: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 81: Belgium Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 82: Belgium GDP and Population, 2018-2019 ($)
Figure 83: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 84: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 85: Spain Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 86: Spain GDP and Population, 2018-2019 ($)
Figure 87: Spain GDP – Composition of 2018, By Sector of Origin
Figure 88: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 89: Denmark Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 90: Denmark GDP and Population, 2018-2019 ($)
Figure 91: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 92: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 93: APAC Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 94: China Generalized Anxiety Disorder Market Value & Volume, 2019-2024
Figure 95: China GDP and Population, 2018-2019 ($)
Figure 96: China GDP – Composition of 2018, By Sector of Origin
Figure 97: China Export and Import Value & Volume, 2018-2019 ($) Generalized Anxiety Disorder Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 98: Australia Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 99: Australia GDP and Population, 2018-2019 ($)
Figure 100: Australia GDP – Composition of 2018, By Sector of Origin
Figure 101: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 102: South Korea Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 103: South Korea GDP and Population, 2018-2019 ($)
Figure 104: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 105: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 106: India Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 107: India GDP and Population, 2018-2019 ($)
Figure 108: India GDP – Composition of 2018, By Sector of Origin
Figure 109: India Export and Import Value & Volume, 2018-2019 ($)
Figure 110: Taiwan Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 111: Taiwan GDP and Population, 2018-2019 ($)
Figure 112: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 113: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 114: Malaysia Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 115: Malaysia GDP and Population, 2018-2019 ($)
Figure 116: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 117: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 118: Hong Kong Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 119: Hong Kong GDP and Population, 2018-2019 ($)
Figure 120: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 121: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 122: Middle East & Africa Generalized Anxiety Disorder Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 123: Russia Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 124: Russia GDP and Population, 2018-2019 ($)
Figure 125: Russia GDP – Composition of 2018, By Sector of Origin
Figure 126: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 127: Israel Generalized Anxiety Disorder Market Value & Volume, 2019-2024 ($)
Figure 128: Israel GDP and Population, 2018-2019 ($)
Figure 129: Israel GDP – Composition of 2018, By Sector of Origin
Figure 130: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 131: Entropy Share, By Strategies, 2018-2019* (%) Generalized Anxiety Disorder Market 
Figure 132: Developments, 2018-2019* Generalized Anxiety Disorder Market 
Figure 133: Company 1 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 134: Company 1 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 135: Company 1 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 136: Company 2 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 137: Company 2 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 138: Company 2 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 139: Company 3 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 140: Company 3 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 141: Company 3 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 142: Company 4 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 143: Company 4 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 144: Company 4 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 145: Company 5 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 146: Company 5 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 147: Company 5 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 148: Company 6 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 149: Company 6 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 150: Company 6 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 151: Company 7 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 152: Company 7 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 153: Company 7 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 154: Company 8 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 155: Company 8 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 156: Company 8 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 157: Company 9 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 158: Company 9 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 159: Company 9 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 160: Company 10 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 161: Company 10 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 162: Company 10 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 163: Company 11 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 164: Company 11 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 165: Company 11 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 166: Company 12 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 167: Company 12 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 168: Company 12 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 169: Company 13 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 170: Company 13 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 171: Company 13 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 172: Company 14 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 173: Company 14 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 174: Company 14 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)
Figure 175: Company 15 Generalized Anxiety Disorder Market Net Revenue, By Years, 2018-2019* ($)
Figure 176: Company 15 Generalized Anxiety Disorder Market Net Revenue Share, By Business segments, 2018 (%)
Figure 177: Company 15 Generalized Anxiety Disorder Market Net Sales Share, By Geography, 2018 (%)